title: (18)F-FET-PET in Primary Hyperparathyroidism: A Pilot Study.
abstract: Preoperative localisation of the diseased parathyroid gland(s) in primary hyperparathyroidism (PHP) is a prerequisite for subsequent minimally invasive surgery. Recently, as alternatives to conventional sestamibi parathyroid scintigraphy, the (11)C-based positron emission tomography (PET) tracers methionine and choline have shown promise for this purpose. We evaluated the feasibility of using the (18)F-based PET tracer fluoroethyl-l-tyrosine (FET), as the longer half-life of (18)F makes it logistically more favourable. As a proof-of-concept study, we included two patients with PHP in which dual-isotope parathyroid subtraction single photon emission computed tomography had determined the exact location of the parathyroid adenoma. A dynamic FET PET/CT scan was performed with subsequent visual evaluation and calculation of target-to-background (TBR; parathyroid vs. thyroid). The maximum TBR in the two patients under study was achieved approximately 30 min after the injection of the tracer and was 1.5 and 1.7, respectively. This ratio was too small to allow for confident visualisation of the adenomas. FET PET/CT seems not feasible as a preoperative imaging modality in PHP.
authors.affiliation: Department of Clinical Physiology and Nuclear Medicine, Gentofte Hospital, DK-2900 Hellerup, Denmark. martin.krakauer@regionh.dk.
authors.forename: Martin
authors.initials: M
authors.lastname: Krakauer
authors.affiliation: Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, DK-2100 Copenhagen, Denmark. andreas.kjaer@regionh.dk.
authors.forename: Andreas
authors.initials: A
authors.lastname: Kjaer
authors.affiliation: Department of Endocrinology, Herlev Hospital, DK-2730 Herlev, Denmark. finn.noe.bennedbaek@regionh.dk.
authors.forename: Finn N
authors.initials: FN
authors.lastname: Bennedbæk
keywords: ">l-tyrosine; (18F)fluoroethyl-; positron-emission tomography; primary hyperparathyroidism